home / stock / lpcn / lpcn news


LPCN News and Press, Lipocine Inc. From 09/21/20

Stock Information

Company Name: Lipocine Inc.
Stock Symbol: LPCN
Market: NASDAQ
Website: lipocine.com

Menu

LPCN LPCN Quote LPCN Short LPCN News LPCN Articles LPCN Message Board
Get LPCN Alerts

News, Short Squeeze, Breakout and More Instantly...

LPCN - Lipocine Announces Completion of Enrollment in the LPCN 1144 LiFT Study

Lipocine Announces Completion of Enrollment in the LPCN 1144 LiFT Study Phase 2 Clinical Study Investigating LPCN 1144 in Biopsy-Confirmed Non-Cirrhotic NASH Subjects PR Newswire SALT LAKE CITY, Sept. 21, 2020 SALT LAKE CITY , Sept. 21, 2020 /PRNewswire/ ...

LPCN - Penny Stocks To Watch If You Like Biotech; 1 Up 287% Year To Date

Putting Together Your List Of Penny Stocks To Watch? Do you like biotech penny stocks ? You’re likely among a unique group of investors that can handle risk. When it comes to these cheap stocks, not only does volatility play a role, so does speculation. Most small-cap biotech stocks ...

LPCN - Lipocine to Participate in HC Wainwright Annual Global Investment Conference

SALT LAKE CITY , Sept. 8, 2020 /PRNewswire/ -- Lipocine Inc. (NASDAQ: LPCN), a clinical-stage biopharmaceutical company focused on metabolic and endocrine disorders, today announced that it will provide a corporate update at the 22 nd HC Wainwright Annual Global Investment Conference. Th...

LPCN - BIGC, NIO among premarket losers

Shiloh Industries (NASDAQ: SHLO )   -50%  after entering into stock and asset purchase agreement with Grouper Holdings. More news on: Shiloh Industries, Inc., Lipocine Inc., PEDEVCO Corp., , Stocks on the move, Read more ...

LPCN - Fortress Reports Positive Data And Other News: The Good, Bad And Ugly Of Biopharma

Fortress Biotech reports positive data from CUTX-101 Fortress Biotech Inc. ( FBIO ) reported positive topline clinical efficacy data for CUTX-101. The trial is being conducted by its partner company Cyprium Therapeutics. The data showed the drug candidate brought about statistically sign...

LPCN - Lipocine under pressure on extended timeline for FDA review of Tlando application

The FDA has informed Lipocine (NASDAQ: LPCN ) that it needs more time to complete its review of the company's marketing application for oral testosterone replacement therapy Tlando (testosterone undecanoate). The agency's action date was today. More news on: Lipocine Inc., Healthcare s...

LPCN - Lipocine Provides Regulatory Update for TLANDO(TM)

SALT LAKE CITY , Aug. 28, 2020 /PRNewswire/ -- Lipocine Inc. (NASDAQ: LPCN), a clinical-stage biopharmaceutical company focused on metabolic and endocrine disorders, today announced that the U.S. Food and Drug Administration ("FDA") has informed the Company that it needs additional t...

LPCN - WDAY, ULTA among premarket gainers.

Nortech Systems NSYS +60% on completing sale-leaseback. More news on: Medigus Ltd., China Liberal Education Holdings Limited, Pacific Ethanol, Inc., Stocks on the move, , Read more ...

LPCN - 3 Penny Stocks To Watch As Health Care Sector Surges

Are These Penny Stocks On Your Watch List? In 2020, penny stocks are catching the eye of many new investors. This generally refers to stocks under $5. This year has brought in an increased amount of investors into the market because of the current economic situation. Some penny stocks have b...

LPCN - CRM, GTX, PLAN and URBN among midday movers

Gainers:  Fluidigm Corporation (NASDAQ: FLDM ) +33% . More news on: Fluidigm Corporation, SCWorx Corp., Anaplan, Inc., Stocks on the move, Read more ...

Previous 10 Next 10